Why is "Adefovir" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-26 03:27:16
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Adefovir is a prescription medicine used to treat (chronic) infections with hepatitis B virus. A prodrug form of adefovir was previously called bis-POM PMEA, with trade names Preveon and Hepsera. It is an orally administered nucleotide analog reverse-transcriptase inhibitor (ntRTI). It can be formulated as the pivoxil prodrug adefovir dipivoxil.
Read more on Wikipedia →Related Topics
- ATC code D06
- ATC code J05
- ATC code S01
- Academy of Sciences of the Czech Republic
- Aciclovir
- Adenine
- Amenamevir
- American Society of Health-System Pharmacists
- Aminotransferase
- Anatomical Therapeutic Chemical Classification System
Trending Topic Today
Search Interest Perspective
-
Adefovir dipivoxil-induced hypophosphatemic osteomalacia and osteoporosis: a case report and literature review - Frontiers
-
Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B - NEJM
-
Adefovir dipivoxil-associated Fanconi syndrome combined with peripheral neuropathy: a case report and literature review - Frontiers
-
Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection - PNAS
-
Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies - Nature
-
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study - The Lancet
-
Adefovir accumulation and nephrotoxicity in renal interstitium: Role of organic anion transporters of kidney - ScienceDirect.com
-
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B - NEJM
-
Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity - Nature
-
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B - NEJM
-
Self-nanoemulsifying drug delivery system for adefovir dipivoxil: Design, characterization, in vitro and ex vivo evaluation - ScienceDirect.com
-
Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System - Frontiers
-
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B - NEJM
-
Absorption enhancement of adefovir dipivoxil by incorporating MCT and ethyl oleate complex oil phase in emulsion - Nature
-
Variant of Hepatitis B Virus with Primary Resistance to Adefovir - NEJM
-
Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B - NEJM
-
Adefovir Dipivoxil for Chemotherapy-Induced Activation of Hepatitis B Virus Infection - NEJM
-
Variant of Hepatitis B Virus with Primary Resistance to Adefovir - NEJM
-
Adefovir Dipivoxil for Chemotherapy-Induced Activation of Hepatitis B Virus Infection - NEJM
-
Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil - ScienceDirect.com
-
Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity - Frontiers
-
Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B - Nature
-
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study - The Lancet
-
Taking Antivirals Long-Term for Hepatitis B? Should You Worry About Bone Loss? - Hepatitis B Foundation
-
GlaxoSmithKline and Gilead announce agreement to commercialise Viread® for chronic hepatitis B in key Asian countries - GSK
-
Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition - Frontiers
-
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B - Nature
-
Experimental and Therapeutic Medicine - Spandidos Publications
-
FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry - Frontiers
-
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B - NEJM
-
Viral hepatitis B - The Lancet
-
Tenofovir Disoproxil Fumarate in Patients with HIV and Lamivudine-Resistant Hepatitis B Virus - NEJM
-
Gilead Sciences and IOCB Prague renew partnership - Akademie věd
-
Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk - Aidsmap
-
Belgian scientists use HIV drug to treat bananas - CORDIS
-
First Hepatitis B Guidelines Update In The Last 5 Years Released By EASL - Life4me+
-
Telbivudine, a New Hepatitis B Drug is effective to prevent Death - healthjockey.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.